Hans Preusting has over 30 years of experience in the Life Science sector and previously served as Chief Business Officer and interim COO of uniQure. He is co-founder of two biotech start-up companies. One of them is DegenRx B.V., which was built based on his gene therapy experience at his time at uniQure. He holds two patents and has published over 20 scientific articles. His expertise is focused on business development, product development and manufacturing. He earned a PhD in biochemistry from the University of Groningen and an MBA from Rotterdam School of Management, The Netherlands.